Ignite Creation Date:
2025-12-25 @ 1:35 AM
Ignite Modification Date:
2025-12-25 @ 11:49 PM
Study NCT ID:
NCT06175494
Status:
RECRUITING
Last Update Posted:
2024-04-23
First Post:
2023-12-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Booster Vaccination With Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell)
Sponsor:
WestVac Biopharma Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-19
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-01-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-12-18
First Submit QC Date:
None
Study First Post Date:
2023-12-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-22
Last Update Post Date:
2024-04-23
Last Update Post Date Type:
ACTUAL